The public health risk remains low, but bird flu variants have proven to be unpredictable, which is why the virus is a top priority for the federal government.

Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an mRNA-based bird flu vaccine, health officials said.

The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.

Cases of norovirus infections are surging, but coming up with a way to prevent them has proven to be a challenge.

The US Department of Health and Human Services will award $590 million to Moderna to continue developing a vaccine to protect against bird flu, the pharmaceutical company announced Friday.

Moderna receives $590M contract from HHS for mRNA-based bird flu vaccine; up 4% in after-hours trading. Read more here.